A research group led by Associate Professor Tetsuya Muramoto from the Faculty of Science, Toho University, has established a ...
New Early Access Express License provides streamlined, affordable access to foundational CRISPR/Cas9 intellectual property to early-stage innovators DUBLIN and CHESHIRE, England, Feb. 24, 2026 ...
A caffeine-triggered switch that turns CRISPR gene editing on and off inside cells could one day improve cancer therapy.
Scientists at Texas A&M are turning an everyday pick-me-up into a high-tech medical switch. By combining caffeine with CRISPR ...
Phase 1 ATLAS trial to evaluate TK-6302 in patients with advanced PRAME-positive solid tumors authorized for initiationSAN FRANCISCO and BERLIN, ...
A version of this Priestley Medal address will be presented at the American Chemical Society Spring 2026 meeting ...
Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer Jennifer Doudna wants to build an entire ecosystem to bring these treatments ...
While caffeine is usually associated with energy and focus, scientists are now exploring a very different use for it. New research suggests that caffeine could someday help control advanced medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results